rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
46
|
pubmed:dateCreated |
2010-11-8
|
pubmed:abstractText |
A growing number of studies indicate that chronic stress can accelerate tumor growth due to sustained sympathetic nervous system activation. Our recent findings suggest that chronic stress is associated with increased IL8 levels. Here, we examined the molecular and biological significance of IL8 in stress-induced tumor growth. Norepinephrine (NE) treatment of ovarian cancer cells resulted in a 250-300% increase in IL8 protein and 240-320% increase in its mRNA levels. Epinephrine treatment resulted in similar increases. Moreover, NE treatment resulted in a 3.5-4-fold increase in IL8 promoter activity. These effects were blocked by propranolol. Promoter deletion analyses suggested that AP1 transcription factors might mediate catecholamine-stimulated up-regulation of IL8. siRNA inhibition studies identified FosB as the pivotal component responsible for IL8 regulation by NE. In vivo chronic stress resulted in increased tumor growth (by 221 and 235%; p < 0.01) in orthotopic xenograft models involving SKOV3ip1 and HeyA8 ovarian carcinoma cells. This enhanced tumor growth was completely blocked by IL8 or FosB gene silencing using 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine nanoliposomes. IL8 and FosB silencing reduced microvessel density (based on CD31 staining) by 2.5- and 3.5-fold, respectively (p < 0.001). Our findings indicate that neurobehavioral stress leads to FosB-driven increases in IL8, which is associated with increased tumor growth and metastases. These findings may have implications for ovarian cancer management.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1083-351X
|
pubmed:author |
pubmed-author:ArevaloJesusa MJM,
pubmed-author:Armaiz-PenaGuillermo NGN,
pubmed-author:Bar-EliMenasheM,
pubmed-author:Bottsford-MillerJustinJ,
pubmed-author:ColeSteven WSW,
pubmed-author:JenningsNicholas BNB,
pubmed-author:LeeJeong-WonJW,
pubmed-author:Lopez-BeresteinGabrielG,
pubmed-author:LuChunhuaC,
pubmed-author:LutgendorfSusan KSK,
pubmed-author:Moreno-SmithMyrthalaM,
pubmed-author:NishimuraMasatoM,
pubmed-author:ShahzadMian M KMM,
pubmed-author:SoodAnil KAK,
pubmed-author:StoneRebecca LRL,
pubmed-author:Vivas-MejiaPabloP
|
pubmed:issnType |
Electronic
|
pubmed:day |
12
|
pubmed:volume |
285
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
35462-70
|
pubmed:dateRevised |
2011-11-14
|
pubmed:meshHeading |
pubmed-meshheading:20826776-Animals,
pubmed-meshheading:20826776-Cell Line, Tumor,
pubmed-meshheading:20826776-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:20826776-Female,
pubmed-meshheading:20826776-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:20826776-Humans,
pubmed-meshheading:20826776-Immunohistochemistry,
pubmed-meshheading:20826776-Interleukin-8,
pubmed-meshheading:20826776-Mice,
pubmed-meshheading:20826776-Mice, Nude,
pubmed-meshheading:20826776-Models, Biological,
pubmed-meshheading:20826776-Neoplasm Metastasis,
pubmed-meshheading:20826776-Neoplasms, Experimental,
pubmed-meshheading:20826776-Norepinephrine,
pubmed-meshheading:20826776-Ovarian Neoplasms,
pubmed-meshheading:20826776-Proto-Oncogene Proteins c-fos,
pubmed-meshheading:20826776-RNA Interference,
pubmed-meshheading:20826776-Restraint, Physical,
pubmed-meshheading:20826776-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:20826776-Stress, Psychological,
pubmed-meshheading:20826776-Transplantation, Heterologous,
pubmed-meshheading:20826776-Tumor Burden,
pubmed-meshheading:20826776-Tumor Microenvironment,
pubmed-meshheading:20826776-Vasoconstrictor Agents
|
pubmed:year |
2010
|
pubmed:articleTitle |
Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis.
|
pubmed:affiliation |
Department of Gynecologic Oncology, RNA, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|